We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.88B
AUM Growth
+$166M
Cap. Flow
+$4.11M
Cap. Flow %
0.22%
Top 10 Hldgs %
22.77%
Holding
144
New
8
Increased
35
Reduced
48
Closed
8

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$32.4M
2
XOM icon
ExxonMobil
XOM
+$23.8M
3
DHR icon
Danaher
DHR
+$22.8M
4
COST icon
Costco
COST
+$22.6M
5
AEP icon
American Electric Power
AEP
+$21.6M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$25.6M
2
PSX icon
Phillips 66
PSX
+$23.7M
3
D icon
Dominion Energy
D
+$23.2M
4
DOX icon
Amdocs
DOX
+$22.9M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 19.13%
2 Financials 15.58%
3 Energy 10.77%
4 Industrials 10.37%
5 Consumer Staples 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$382B
$50.5M 2.69%
95,210
+1,100
+1% +$583K
AJG icon
2
Arthur J. Gallagher & Co
AJG
$63.7B
$47.2M 2.52%
250,380
+38,580
+18% +$7.22M
LLY icon
3
Eli Lilly
LLY
$1.07T
$43.9M 2.34%
119,900
-29,200
-20% -$10.4M
GD icon
4
General Dynamics
GD
$105B
$43.3M 2.31%
174,330
-4,500
-3% -$1.1M
JPM icon
5
JPMorgan Chase
JPM
$939B
$42.8M 2.28%
319,460
+6,900
+2% +$874K
NEE icon
6
NextEra Energy
NEE
$187B
$42M 2.24%
502,600
+12,300
+3% +$994K
RSG icon
7
Republic Services
RSG
$66.7B
$41.2M 2.2%
319,450
+107,030
+50% +$14.3M
CVS icon
8
CVS Health
CVS
$137B
$40.6M 2.17%
436,200
+29,000
+7% +$2.8M
CB icon
9
Chubb
CB
$140B
$38.2M 2.04%
173,170
– –
MRK icon
10
Merck
MRK
$324B
$37.5M 2%
338,010
-66,200
-16% -$6.77M
MET icon
11
MetLife
MET
$61B
$35.1M 1.87%
484,640
– –
GIS icon
12
General Mills
GIS
$19.2B
$34.9M 1.86%
415,800
+161,400
+63% +$13.1M
ELV icon
13
Elevance Health
ELV
$81.9B
$34.8M 1.86%
67,900
+1,500
+2% +$762K
ABBV icon
14
AbbVie
ABBV
$458B
$33.7M 1.79%
208,270
-42,800
-17% -$6.56M
HYG icon
15
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$32.4M 1.73%
+439,600
New +$32.4M
AAPL icon
16
Apple
AAPL
$4.89T
$32.1M 1.71%
246,950
+92,090
+59% +$13.2M
BMY icon
17
Bristol-Myers Squibb
BMY
$127B
$31.9M 1.7%
443,060
-4,200
-0.9% -$317K
CVX icon
18
Chevron
CVX
$388B
$31.4M 1.67%
175,000
-1,300
-0.7% -$227K
MSFT icon
19
Microsoft
MSFT
$2.84T
$31.1M 1.66%
129,830
+600
+0.5% +$144K
PEP icon
20
PepsiCo
PEP
$186B
$30.8M 1.64%
170,300
+1,600
+0.9% +$285K
MCD icon
21
McDonald's
MCD
$188B
$30.6M 1.63%
116,020
+1,600
+1% +$422K
KO icon
22
Coca-Cola
KO
$354B
$30.1M 1.6%
473,310
-99,910
-17% -$6.03M
SPY icon
23
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$28.8M 1.53%
75,197
-230
-0.3% -$88.4K
HD icon
24
Home Depot
HD
$332B
$28.1M 1.5%
88,870
+25,400
+40% +$7.74M
BAC icon
25
Bank of America
BAC
$435B
$28.1M 1.5%
847,090
+576,300
+213% +$19.9M
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q4 2022 Portfolio in Review

As of Q4 2022, Payden & Rygel held 144 positions worth $1.88B, up 9.7% from $1.71B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Payden & Rygel's Q4 2022 filing shows 8 new, 35 increased, 48 reduced and 8 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 439,600 shares worth $32.4M. The largest sale was Exelon, an estimated $25.6M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Energy.

  • Payden & Rygel's largest Q4 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 439,600 shares worth $32.4M.
  • Payden & Rygel added most to ExxonMobil in Q4 2022, an estimated $23.8M increase.
  • Payden & Rygel's biggest Q4 2022 reduction was Exelon, cutting an estimated $25.6M.
  • Payden & Rygel fully exited Amdocs in Q4 2022, selling an estimated $22.9M.
  • Payden & Rygel's ten largest holdings make up 23% of its $1.88B portfolio in Q4 2022.
  • Payden & Rygel opened 8 new positions and closed 8 in Q4 2022.
  • Payden & Rygel's portfolio value rose 9.7% quarter-over-quarter to $1.88B.

Based on Payden & Rygel's 13F filing for Q4 2022, filed 13 Feb 2023.